Cephalosporin compound
US8809314B1 · kind B1 · utility
10Cited by
171References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2013 |
| Grant date | Aug 19, 2014 |
| Priority date | — |
| Expiry date | Sep 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D501/56
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The cephalosporin compound of formula (I) is disclosed, which exhibits antibiotic activity against Gram-negative (e.g., Pseudomonas aeruginosa) and Gram-positive (e.g., methicillin-resistant Staphylococcus aureus) bacteria. Methods of manufacturing the compound of formula (I), and uses of the compound in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.